Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Interest & Investment Income (2023 - 2025)

Biofrontera (BFRI) has 3 years of Interest & Investment Income data on record, last reported at -$111000.0 in Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 1487.5% year-over-year to -$111000.0; the TTM value through Sep 2025 reached -$2.4 million, down 22.7%, while the annual FY2024 figure was -$2.0 million, 1641.67% down from the prior year.
  • Interest & Investment Income reached -$111000.0 in Q3 2025 per BFRI's latest filing, up from -$234000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $56000.0 in Q1 2023 and bottomed at -$2.1 million in Q4 2024.
  • Average Interest & Investment Income over 3 years is -$389545.5, with a median of $8000.0 recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: crashed 10057.14% in 2024, then skyrocketed 101.0% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $21000.0 in 2023, then plummeted by 10057.14% to -$2.1 million in 2024, then soared by 94.69% to -$111000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were -$111000.0 in Q3 2025, -$234000.0 in Q2 2025, and $14000.0 in Q1 2025.